This drug is presumably believed to induce IH tumor regression through mechanisms similar to that noted in normal endothelial cells, and recent reports suggest that it may work in part through suppressing production of nitric oxide and HIF1α regulation of VEGF expression (10,11). Here, VEGFA is linked to neoplasm.